IDIBELL researchers discover that a molecule of blood is effective against autoimmune kidney disease
The administration of C4BP (beta-) in mice that reproduce lupus nephritis considerably improves the symptomatology of the disease.
2020
The agreement of the audiovisual project ‘What and how to eat during cancer’ was presented
When a cancer is diagnosed, a host of questions spring to the patient’s: about medical treatment, new day-to-day, his new life … Also about a new way of feeding. An adequate diet is essential to guarantee the good nutritional status in order to tolerate these cancer treatments. In short, it is key to cope with the disease.
Identified a determinant protein for tumor progression and metastasis in childhood cancer Rhabdomyosarcoma
LOXL2 protein levels are increased in the cells from this type of sarcoma.
Inhibition of p38 reduces the growth of lung tumors
The work shows that patients with low levels of this protein have a better prognosis.
Inhibition of p38 reduces the growth of lung tumors Read More »
IDIBELL researchers Antonella Consiglio and Ángel Raya, awarded with the City of Barcelona Award
Two researchers from the Bellvitge Biomedical Research Institute (IDIBELL), have been awarded in this edition of the City of Barcelona Awards, in the Life Sciences category. Dr. Antonella Consiglio, principal investigator of the group of stem cells and neurodegenerative diseases of IDIBELL, ICREA academy researcher, and professor at the Faculty of Medicine and Health Sciences
On World Cancer Day we will celebrate HealthTech World Day
In World Cancer Day, NanoMed organizes the seventh edition of the HealthTech World Cancer Day. An event in which the latest innovations in nanomedicine cancer filed, will be announced. Experts will talk about issues ranging from early diagnosis, controlled drug release or radiotherapy with nanoparticles. The Bioengineering Institute of Catalonia (IBEC) and the Bellvitge Biomedical
On World Cancer Day we will celebrate HealthTech World Day Read More »
Dimethyl fumarate obtained orphan drug designation for the treatment of adrenoleukodystrophy
The European Medicines Agency (EMA) has approved dimethyl fumarate (DMF) as an orphan drug for the treatment of adrenoleukodystrophy, a rare fatal neurometabolic disorder. Dimethyl fumarate is an activator of the NFR2 pathway, which enhances cellular defense and protection against oxidative damage. Dimethyl fumarate can reduce the inflammatory response and promote the protection of central
Catalan researchers propose a new protocol for an endoscopic puncture in the pancreas
A group of Catalan researchers, led by the director of the digestive endoscopy Unit of the Digestive Pathology Service of the Hospital de Sant Pau de Barcelona – IIB Sant Pau, Carles Guarner Argente, have published an article in Gastroenterology in which, it is shown that the antibiotic prophylaxis is not necessary for ultrasound-guided endoscopic
Catalan researchers propose a new protocol for an endoscopic puncture in the pancreas Read More »
Avatar worms help to identify factors that modify genetic diseases
IDIBELL researchers have used gene-editing technology in C. elegans to reproduce human mutations that cause retinitis pigmentaria. With this method, they have studied factors that affect disease development and possible drug treatments. Often, patients from the same family and carriers of the same genetic mutation, develop a disease differently. This disparity may be due
Avatar worms help to identify factors that modify genetic diseases Read More »
3rd SLHAM of women scientists of IDIBELL arrives
The 3rd SLHAM of women scientists will take place on Saturday, February 8 at 7 pm at the Auditori Barradas, in L’Hospitalet. Nine women researchers and professionals from the Bellvitge Biomedical Research Institute (IDIBELL) will participate. Each of them will explain their work concerning research and innovation through a five-minute informative talk. The 2020 edition
3rd SLHAM of women scientists of IDIBELL arrives Read More »